1994
DOI: 10.1016/0003-4975(94)92254-3
|View full text |Cite
|
Sign up to set email alerts
|

Clinical implantation of the wearable baxter Novacor ventricular assist system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

1995
1995
2011
2011

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 34 publications
(9 citation statements)
references
References 7 publications
0
9
0
Order By: Relevance
“…Furthermore, the autonomy gained unquestionably increases the patient's emotional well-being. 60,61 After implantation of a left ventricular assist device, patients can often return to work and engage in other activities, including gardening, dancing, and driving. 23 Of 24 patients treated by us who were discharged home on mechanical support, 6 returned to school and 5 returned to work.…”
Section: Patients' Adaptation To the Devicementioning
confidence: 99%
“…Furthermore, the autonomy gained unquestionably increases the patient's emotional well-being. 60,61 After implantation of a left ventricular assist device, patients can often return to work and engage in other activities, including gardening, dancing, and driving. 23 Of 24 patients treated by us who were discharged home on mechanical support, 6 returned to school and 5 returned to work.…”
Section: Patients' Adaptation To the Devicementioning
confidence: 99%
“…Mechanical circulatory support (MCS) in France was, until recently, an activity performed by only a small number of surgical centers [1][2][3][4][5]. These pioneer centers, which have deployed much effort in terms of financial and organizational resources, have contributed to the development and credibility of this therapeutic tool among both health-care professionals and administrative authorities.…”
Section: Introductionmentioning
confidence: 99%
“…[13][14][15][16][17] The utility of shortterm devices, such the Medos, 18 Abiomed and Impella, has been shown in primary graft failure and post-cardiotomy, but the first 2 of these devices have significant risks of thromboembolism, bleeding and infection, raising the clinical cost. Moreover, the Abiomed BVS 500, the most widely used in this category, still has several limitations, including: pump-related complications (seal disruption); the patient's continued sedation and inability to ambulate; and a maximum achievable flow of 6 liters, which is sometimes not sufficient in septic patients.…”
Section: Discussionmentioning
confidence: 99%